Authors:
CHENE G
MORLAT P
LEPORT C
HAFNER R
DEQUAE L
CHARREAU I
ABOULKER JP
LUFT B
AUBERTIN J
VILDE JL
SALAMON R
Citation: G. Chene et al., INTENTION-TO-TREAT VS. ON-TREATMENT ANALYSES OF CLINICAL-TRIAL DATA -EXPERIENCE FROM A STUDY OF PYRIMETHAMINE IN THE PRIMARY PROPHYLAXIS OF TOXOPLASMOSIS IN HIV-INFECTED PATIENTS, Controlled clinical trials, 19(3), 1998, pp. 233-248
Authors:
BRUNVEZINET F
BOUCHER C
LOVEDAY C
DESCAMPS D
FAUVEAU V
IZOPET J
JEFFRIES D
KAYE S
KRZYANOWSKI C
NUNN A
SCHUURMAN R
SEIGNEURIN JM
TAMALET C
TEDDER R
WEBER J
WEVERLING GJ
ABER V
ABOULKER JP
BABIKER AG
BRAGMAN K
BRECKENRIDGE AM
CARBON C
CHARREAU I
CHENE G
COLLIS P
COOPER D
DARBYSHIRE JH
DORMONT J
FIDDIAN P
FLEPP M
GAZZARD B
GOEBEL FD
HOOKER M
LANGE J
LUTHY R
PETO TEA
REISS P
SELIGMANN M
STONE AB
THOMIS J
VELLA S
WALCKENAER G
WARRELL D
WELLER IVD
WILBER R
YENI P
YEO J
WITHNALL R
BABIKER A
BLOCH J
POUCHER C
DARBYSHIRE J
GOUDSMIT J
HURAUX JM
VANDERNOORDAA J
WEISS R
WEVERLING G
Citation: F. Brunvezinet et al., HIV-1 VIRAL LOAD, PHENOTYPE, AND RESISTANCE IN A SUBSET OF DRUG-NAIVEPARTICIPANTS FROM THE DELTA-TRIAL, Lancet, 350(9083), 1997, pp. 983-990
Authors:
CARBON C
WARRELL D
ABOULKER JP
COOPER DA
DARBYSHIRE JH
DORMONT J
FLEPP M
LANGE J
LEVY JP
MATHIESEN L
PETO TEA
PINCHING AJ
REISS P
SCHWARTZ D
SELIGMANN M
STONE A
THOMIS J
WITHNALL R
BARKER S
FRISSEN PJ
DEJONG MD
LOEWENTHAL M
TOURNERIE C
VALENTINE C
ABER V
BABIKER AG
CHARREAU I
THAKRAR B
VRAY M
LUTHY R
Citation: C. Carbon et al., THE ALPHA-TRIAL - EUROPEAN AUSTRALIAN RANDOMIZED DOUBLE-BLIND TRIAL OF 2 DOSES OF DIDANOSINE IN ZIDOVUDINE-INTOLERANT PATIENTS WITH SYMPTOMATIC HIV DISEASE/, AIDS, 10(8), 1996, pp. 867-880
Authors:
ABER V
ABOULKER JP
BABIKER AG
BRAGMAN K
BRECKENRIDGE AM
CARBON C
CHARREAU I
CHENE G
COLLIS P
COOPER D
DARBYSHIRE JH
DORMONT J
FIDDIAN P
FLEPP M
GAZZARD B
GOEBEL FD
HOOKER M
LANGE J
LUTHY R
PETO TEA
REISS P
SELIGMANN M
STONE AB
THOMIS J
VELLA S
WALCKENAER G
WARRELL D
WELLER IVD
WILBER R
YENI P
YEO J
WITHNALL R
Citation: V. Aber et al., DELTA - A RANDOMIZED DOUBLE-BLIND CONTROLLED TRIAL COMPARING COMBINATIONS OF ZIDOVUDINE PLUS DIDANOSINE OR ZALCITABINE WITH ZIDOVUDINE ALONE IN HIV-INFECTED INDIVIDUALS, Lancet, 348(9023), 1996, pp. 283-291